Peripartum cardiomyopathy: review and practice guidelines.

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Critical Care Medicine

Background:

• Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy with unknown etiology.
• It affects previously healthy women during the last month of pregnancy or up to five months postpartum.
• PPCM has a low incidence (<0.1% of pregnancies) but high morbidity and mortality rates (5-32%).

Purpose of the Study:

• To summarize the clinical presentation, management, and outcomes of peripartum cardiomyopathy.
• To highlight the variability in patient outcomes, ranging from full recovery to severe cardiac failure and death.

Main Methods:

• Review of existing literature on peripartum cardiomyopathy.
• Analysis of treatment strategies including medical management and mechanical circulatory support.
• Discussion of long-term outcomes and risk of recurrence.

Main Results:

• Outcomes for PPCM are highly variable; some patients experience improvement, while others progress to severe heart failure or sudden cardiac death.
• Acute care may involve vasodilators, inotropic agents, intra-aortic balloon pumps, ventricular-assist devices, or ECMO.
• Survivors may recover left ventricular function but face risks in subsequent pregnancies.

Conclusions:

• Peripartum cardiomyopathy presents a significant risk to maternal health, necessitating prompt diagnosis and management.
• Survivors with chronic left ventricular dysfunction require ongoing management guided by established cardiology guidelines.
• The potential for recurrence in future pregnancies underscores the importance of careful monitoring and counseling.